Erratum: Synthesis and evaluation of fluorine-18 labeled glyburide analogs as β-cell imaging agents (Nuclear Medicine and Biology (2004) 31 (483-491) DOI: 10.1016/j.nucmedbio.2003.12.003);Synthesis and evaluation of fluorine-18 labeled glyburide analogs as β-cell imaging agents

Nuclear Medicine and Biology

Volumn 31, Issue 4, 2004, Pages 483-491

  Schmitz, A ^a   Shiue, C Y ^a   Feng, Q ^a   Shiue, G G ^a   Deng, S ^a   Pourdehnad, M T ^a   Schirrmacher, R ^b   Vatamaniuk, M ^a   Doliba, N ^a   Matschinsky, F ^a   Wolf, B ^a   Rosch F ^b   Naji, A ^a   Alavi, A A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

2 18F fluoroethoxy 5 iodoglyburide; 2 18F fluoroethoxyglyburide; Diabetes; Sulfonylurea receptors; cell imaging agents

Indexed keywords

2 FLUOROETHOXY 5 DESCHLORO 5 IODOGLYBURIDE F 18; 2 FLUOROETHOXYGLYBURIDE F 18; DIMETHYL SULFOXIDE; GLIBENCLAMIDE; INSULIN; N [4 [BETA [2 (2' FLUOROETHOXY) 5 CHLOROBENZENECARBOXAMIDO]ETHYL]BENZENESULFONYL] N' CYCLOHEXYLUREA F 18; N [4 [BETA [2 (2' FLUOROETHOXY) 5 IODOBENZENECARBOXAMIDO]ETHYL]BENZENESULFONYL] N' CYCLOHEXYLUREA F 18; OCTANOL; TRACER; UNCLASSIFIED DRUG; UREA DERIVATIVE; WATER;

ALKYLATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SCREENING; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSULIN RELEASE; LIVER; MOUSE; NONHUMAN; SMALL INTESTINE;

EID: 11144354518     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.12.002     Document Type: Erratum

References (32)

1. Taylor S.I. Deconstructing type 2 diabetes. Cell. 97:1999;9-12.
2. DeFronzo R Pathogenesis of type-2 diabetes - metabolic and molecular implications for identifying diabetes genes. Diabetes Rev1997;5:177-269.
3. Chehade J.M., Mooradian A.D. A rational approach to drug therapy of type 2 diabetes mellitus. Drugs. 60:2000;95-113.
4. Bottino R., Lemarchand P., Trucco M., Giannoukakis N. Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther. 10:2003;875-889.
5. Uchikoshi F., Yang Z.D., Rostami S., Yokoi Y., Capocci P., Barker C.F., Naji A. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes. 48:1999;652-657.
6. Norrchashm H., Noorchashm N., Kern J., Rostami S.Y., Barker C.F., Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes. 46:1997;941-946.
7. Edwards G., Weston A. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol. 33:1993;597-637.
8. Proks P., Reimann F., Green N., Gribble F., Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes. 51:(suppl 3):2002;368-376.
9. Ashcroft SJH, Niki I, Kenna S, Weng L, Skeer L, Coles B, Ashcroft FM. The β-cell sulfonylurea receptor. Adv Exp Med Biol. 1993;334:47-61.
10. Panten U., Schwanstecher M., Schwanstecher C. Pancreatic and extrapancreatic sulfonylurea receptors. Horm Metab Res. 24:1992;549-554.
11. Meyer M., Chudziak F., Schwanstecher C., Schwanstecher M., Panten U. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes. Br J Pharmacol. 128:1999;27-34.
12. Niki I., Welsh M., Berggren P.O., Hubbard P., Ashcroft S.J. Characterization of the solubilized glibenclamide receptor in a hamster pancreatic beta-cell line, HIT T15. Biochem J. 277:1991;619-624.
13. Gaines K.L., Hamilton S., Boyd A.E. III. Characterization of the sulfonylurea receptor on beta cell membranes. J Biol Chem. 263:1988;2589-2592.
14. Schmid-Antomarchi H., De Weille J., Fosset M., Lazdunski M. The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. J Biol Chem. 262:1987;15840-15844.
15. Aguilar-Bryan L., Nichols C.G., Rajan A.S., Parker C., Bryan J. Co-expression of sulfonylurea receptors and KATP channels in hamster insulinoma tumor (HIT) cells. Evidence for direct association of the receptor with the channel. J Biol Chem. 267:1992;14934-14940.
16. Hokfelt B., Jonsson A. Hypoglycemic activity in relation to chemical structure of potential oral antidiabetic substances. I. 1-Sulfonyl-3-alkylureas. J Med Pharm Chem. 5:1962;231-239.
17. Schirrmacher R., Weber M., Schmitz A., Shiue C.-Y., Alavi A.A., Feilen P., Schneider S., Kann P., Rösch F. Radiosynthesis of 1-(4-(2-[18F] Fluoroethoxy)benzenesulfonyl)-3-butyl urea a potential β-cell imaging agent. J Label Compd Radiopharm. 45:2002;763-774.
18. Shiue G.G., Schirrmacher R., Shiue C.-Y., Alavi A.A. Synthesis of fluorine-18 labeled sulfonureas as β-cell imaging agents. J Label Compd Radiopharm. 44:2001;127-139.
19. Shiue C.-Y., Schmitz A., Pourdehnad M.T., Shiue G.G., Vatamaniuk M., Doliba N., Matschinsky F., Wolf B., Alavi A.A., Schirrmacher R. Synthesis of β-cell imaging agents. J Nucl Med. 42:(suppl):2001;72P.
20. Aguilar-Bryan L., Nelson D.A., Vu Q.A., Humphrey M.B., Boyd A.E. III. Photoaffinity labeling and partial purification of the β cell sulfonylurea receptor using a novel, biologically active glyburide analog. J Biol Chem. 265:1990;8218-8224.
21. Herbert V., Lau K.S., Gottlieb C.W., Bleicher S. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 25:1965;1375-1384.
22. Ladriere L., Malaisse-Lagae F., Malaisse W.J. Pancreatic uptake of 65zinc in control and streptozotocin injected rats. Med Sci Res. 28:2000;43-44.
23. Malaisse W.J. On the track to the beta-cell. Diabetologia. 44:2001;393-406.
24. Ladriere L., Malaisse-Lagae F., Alejandro R., Malaisse W.J. Pancreatic fate of a 125I-labeled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats. Cell Biochem Funct. 19:2001;107-115.
25. Moore A., Bonner-Weir S., Weissleder R. Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes. 50:2001;2231-2236.
26. Hwang D.R., Pham V., Huang Y., Laruelle M., Jerabek P., Fox P., DeFranzo R. Synthesis and in vivo evaluation of [11C]glyburide for imaging pancreatic β-cells. J Label Compd Radiopharm. 46:2003;S352.
27. Carpentier J.-L., Sawano F., Ravazzola M., Malaisse W.J. Internalization of 3H-glibenclamide in pancreatic islet cells. Diabetologia. 29:1986;259-261.
28. Ladriere L., Malaisse-Lagae F., Malaisse W.J. Uptake of tritiated glibenclamide by endocrine and exocrine pancreas. Endocrine. 13:2000;133-136.
29. Fuhlendorff J., Rorsman P., Kofod H., Brand C.L., Rolin B., MacKay P., Shymko R., Carr R.D. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes. 47:1998;345-351.
30. Suzuki M., Fujikura K., Kotake K., Inagaki N., Seino S., Takata K. Immuno-localization of sulphonylurea receptor 1 in rat pancreas. Diabetologia. 42:1999;1204-1211.
31. Suzuki M., Fujikura K., Inagaki N., Seino S., Takata K. Localization of the ATP-sensitive K+ channel subunit Kir6.2 in mouse pancreas. Diabetes. 46:1997;1440-1444.
32. ATP channels. Diabetes. 45:1996;1439-1445.